Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
11 Juli 2015
FDA approves Rexulti (brexpiprazole) as adjunctive treatment for adults with major depressive disorder and as a treatment for adults with schizophrenia
23 Juni 2015
Young adult patients* with schizophrenia show improved functioning and health-related quality of life with Abilify Maintena® (aripiprazole once-monthly) compared with paliperidone palmitate
14 Juni 2015
Major shareholder announcement
2 Juni 2015
Total number of voting rights and share capital in H. Lundbeck A/S as of 31 May 2015
21 Mai 2015
Lundbeck increases its share capital by 186,676 shares (0.0950% of outstanding shares)
6 Mai 2015
Solid performance in the first quarter of the year. Full year guidance maintained